Matthew Crepeau's Contact Details

Matthew Crepeau's Company Details

CuriRx Incorporation

Wilmington, MA, US • 20 - 49 Employees
BioTech/Drugs

CuriRx, Inc. was founded in 2012 with the goal of creating new standards of care in therapeutic areas with high unmet medical needs. We do this by partnering with our clients to provide innovative development solutions for pharmaceutics, biopharmaceutics, vaccines, generics, and biosimilars. Our unique approach allows for:Strong collaborationCustomized development plansOpen discussion with strong consultative expertiseIterative ideationMaximized efficacyGuaranteed commitment and customer satisfactionWe are a contract services company providing research and development for biotech and pharmaceutical products, and our scientists have more than 30 years' experience in formulation development. We have worked with small molecules, peptides, proteins, vaccines, biosimilars, oligonucleotides, bacteria, cells, dextrans, combination products, conjugated products, antibodies, bispecific antibodies, and more. Our services include formulation development, lyophilization, cell culture and purification, analytical development, and more, and we have the capacity to produce non-GMP vials for animal studies and non-GMP stability support studies. Our past successful development projects include HUMIRA® and Synagis®. In addition to our R&D services, we are happy to consult with you in the areas of operational management, project management, GMP, cGMP, customized aseptic technique training, product development, and more.